ArticleBiomedical engineering online2017
Tissue perfusion modelling in optical coherence tomography.
Article in Biomedical engineering online, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- LEVERAGING CONTRAST AGENT KINETICS FOR ROBUST REFLECTANCE MODE FLUORESCENCE TOMOGRAPHY.Proceedings. IEEE International Symposium on Biomedical Imaging · 2025Article
- Mathematical Models for Blood Flow Quantification in Dialysis Access Using Angiography: A Comparative Study.Diagnostics (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOptical coherence tomography (OCT) is a well established imaging technique with different applications in preclinical research and clinical practice. The main potential for its application lies in the possibility of noninvasively performing "optical biopsy". Nevertheless, functional OCT imaging is also developing, in which perfusion imaging is an important approach in tissue function study. In spite of its great potential in preclinical research, advanced perfusion imaging using OCT has not been studied. Perfusion analysis is based on administration of a contrast agent (nanoparticles in the case of OCT) into the bloodstream, where during time it specifically changes the image contrast. Through analysing the concentration-intensity curves we are then able to find out further information about the examined tissue.
methodsWe have designed and manufactured a tissue mimicking phantom that provides the possibility of measuring dilution curves in OCT sequence with flow rates 200, 500, 1000 and 2000 μL/min. The methodology comprised of using bolus of 50 μL of gold nanorods as a contrast agent (with flow rate 5000 μL/min) and continuous imaging by an OCT system. After data acquisition, dilution curves were extracted from OCT intensity images and were subjected to a deconvolution method using an input-output system description. The aim of this was to obtain impulse response characteristics for our model phantom within the tissue mimicking environment. Four mathematical tissue models were used and compared: exponential, gamma, lagged and LDRW.
resultsWe have shown that every model has a linearly dependent parameter on flow ([Formula: see text] values from 0.4914 to 0.9996). We have also shown that using different models can lead to a better understanding of the examined model or tissue. The lagged model surpassed other models in terms of the minimisation criterion and [Formula: see text] value.
conclusionsWe used a tissue mimicking phantom in our study and showed that OCT can be used for advanced perfusion analysis using mathematical model and deconvolution approach. The lagged model with three parameters is the most appropriate model. Nevertheless, further research have to be performed, particularly with real tissue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.